These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Local and systemic adverse effects of imiquimod therapy for external anogenital warts in men: report of three cases. Rosenblatt A; de Campos Guidi HG Int J STD AIDS; 2012 Dec; 23(12):909-10. PubMed ID: 23258837 [TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus-type predict the clinical outcome of imiquimod therapy for women with vulvar condylomata acuminata. Dede M; Kubar A; Yenen MC; Alanbay I; Guven S; Mesten Z; Baser I Acta Obstet Gynecol Scand; 2007; 86(8):968-72. PubMed ID: 17653883 [TBL] [Abstract][Full Text] [Related]
29. Psoriasiform eruption and oral ulcerations as adverse effects of topical 5% imiquimod treatment in children: a report of four cases. Smith WA; Siegel D; Lyon VB; Holland KE Pediatr Dermatol; 2013; 30(6):e157-60. PubMed ID: 22612595 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts. Komericki P; Akkilic-Materna M; Strimitzer T; Aberer W Sex Transm Dis; 2011 Mar; 38(3):216-8. PubMed ID: 20938374 [TBL] [Abstract][Full Text] [Related]
31. Impetigo as an adverse effect of topical 5% imiquimod treatment for viral warts. Heng LW; Chandran NS Int J Dermatol; 2021 Jul; 60(7):909-910. PubMed ID: 33660286 [No Abstract] [Full Text] [Related]
32. Imiquimod 5% cream: a topical immune response modifier. Marini M Int J Dermatol; 2002 May; 41 Suppl 1():1-2. PubMed ID: 12087812 [No Abstract] [Full Text] [Related]
34. Imiquimod as an immune response modulator in infectious conditions. Skinner RB Postgrad Med; 2002 Dec; 112(6 Suppl Using):8-16. PubMed ID: 19667608 [TBL] [Abstract][Full Text] [Related]
35. Vulvar vitiligo-like depigmentation and multiple halos of hypomelanosis at the trunk following treatment with imiquimod 5% cream for vulvar condylomata: casual or related events? Serra MC; Menicanti C; Pennacchioli E; Tosti G An Bras Dermatol; 2014; 89(5):806-7. PubMed ID: 25184923 [TBL] [Abstract][Full Text] [Related]
36. [Imiquimod: immunologic-response modifier]. Berman B Ann Dermatol Venereol; 2000; 127(10 Suppl):3S15-3S18. PubMed ID: 11116858 [No Abstract] [Full Text] [Related]
38. Lack of efficacy of topical imiquimod in the treatment of patchy alopecia areata. Koc E; Tunca M; Akar A; Kurumlu Z Int J Dermatol; 2008 Oct; 47(10):1088-9. PubMed ID: 18986369 [No Abstract] [Full Text] [Related]